Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRYSTAL OF SALT OF NOVEL 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2016/186184
Kind Code:
A1
Abstract:
The objective of the present invention is to provide: a crystal having high purity and excellent properties (such as stability and solubility) of a highly safe compound with few side effects, said compound having μ-opioid receptor antagonist activity; and a method for producing this crystal. A crystal of a salt or hydrate thereof, said salt being composed of a compound represented by formula (I) and an acid selected from the group consisting of hydrochloric acid, hydrobromic acid and oxalic acid. (In the formula, R2 represents a hydrogen atom or a halogen atom; and R1 represents a group selected from the group consisting of formulae AA, BB, CC and DD.)

Inventors:
IWAMURA RYO (JP)
TSUZAKI YASUNORI (JP)
SETOGUCHI HIROYUKI (JP)
AKAZA HIROTO (JP)
YAMAMOTO YASUHITO (JP)
TAKAMA AKIRA (JP)
KUNO YUKA (JP)
Application Number:
PCT/JP2016/064942
Publication Date:
November 24, 2016
Filing Date:
May 19, 2016
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SANWA KAGAKU KENKYUSHO CO (JP)
UBE INDUSTRIES (JP)
International Classes:
C07D209/52; A61K31/403; A61P1/00; A61P1/10; A61P3/04; A61P17/04; A61P25/18; A61P25/24; A61P25/30; A61P25/36; A61P43/00
Domestic Patent References:
WO2015076310A12015-05-28
Foreign References:
JP2002533440A2002-10-08
JP2005511545A2005-04-28
JP2007508367A2007-04-05
Other References:
LUNN,G. ET AL.: "SAR and biological evaluation of 3-azabicyclo[3.1.0]hexane derivatives as mu opioid ligands", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 22, no. 6, 2012, pages 2200 - 2203, XP028402839
See also references of EP 3299357A4
Attorney, Agent or Firm:
SAKAMOTO TOMOHIRO (JP)
坂本 智弘 (JP)
Download PDF: